Oxygen free radical traps for the treatment of ischemia-associated organ injury

Current Opinion in Investigational Drugs

Volumn 5, Issue 1, 2004, Pages 50-54

  Jackson, David M ^a   Sammut, Ivan A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Antioxidants; Ischemic damage; Neuroprotection; Nitrones; Radical traps

Indexed keywords

4 AMINOBUTYRIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; ALPHA TOCOPHEROL; APTIGANEL; ASCORBIC ACID; CLOMETHIAZOLE; DISUFENTON SODIUM; DNA; DOXORUBICIN; EBSELEN; ELIPRODIL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAVESTINEL; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPID; N TERT BUTYL ALPHA PHENYLNITRONE; NITRIC OXIDE; NITRONE DERIVATIVE; NORPHENAZONE; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE; SPERMINE; SUPEROXIDE DISMUTASE; TIRILAZAD;

ACUTE DISEASE; ARTICLE; BRAIN ISCHEMIA; BRAIN TISSUE; CEREBROVASCULAR ACCIDENT; CLINICAL STUDY; CLINICAL TRIAL; DNA DEGRADATION; DRUG BLOOD LEVEL; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; HEART INJURY; HEART MUSCLE ISCHEMIA; HUMAN; LABORATORY TEST; LIPID DEGRADATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; ORGAN INJURY; PROTEIN DEGRADATION; REPERFUSION INJURY; SIDE EFFECT; TISSUE INJURY;

ANIMALS; BENZENESULFONATES; BRAIN ISCHEMIA; FREE RADICAL SCAVENGERS; FREE RADICALS; HUMANS; ISCHEMIA; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NEUROPROTECTIVE AGENTS; NITROGEN OXIDES;

EID: 2342428686     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Baron J-C, Moseley ME: For how long is brain tissue salvageable? Imaging-based evidence. J Stroke Cerebrovasc Dis (2000) 9(6):15-20.
2. Ginsberg MD: Adventures in the pathophysiology of brain ischemia: Penumbra, gene expression, neuroprotection: The 2002 Thomas Willis lecture. Stroke (2003) 34(1):214-223.
3. Bullock R, Zauner A, Woodward J, Young HF: Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke (1995) 26(11):2187-2189.
4. Mottley C, Mason RP: Nitroxide radical adducts in biology: Chemistry applications, and pitfalls. In: Biological Magnetic Resonance. Berliner LJ, Reuben J (Eds), Plenum Publishing, New York, NY, USA (1999) 8:489-546.
5. Toyoda T, Kassell NF, Lee KS: Induction of ischemic tolerance and antioxidant activity by brief focal ischemia. Neuroreport (1997) 8(4):847-851.
6. Ferchmin PA, Pérez D, Biello M: Spermine is neuroprotective against anoxia and N-methyI-D-aspartate in hippocampal slices. Brain Res (2000) 859(2):273-279.
7. Adibhatla RM, Hatcher JF, Sailor K, Dempsey RJ: Polyamines and central nervous system injury: Spermine and spermidine decrease following transient focal cerebral ischemia in spontaneously hypertensive rats. Brain Res (2002) 938(1-2):81-86.
8. Hall ED, McCall JM, Means ED: Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol (1994) 28:221-268.
9. Marklund N, Lewander T, Clausen F, Hillered L: Effects of the nitrone radical scavengers PBN and S-PBN on in vivo trapping of reactive oxygen species after traumatic brain injury in rats. J Cereb Blood Flow Metab (2001) 21(11):1259-1267.
10. Kastrup A, Engelhorn T, Beaulieu C, de Crespigny A, Moseley ME: Dynamics of cerebral injury, perfusion, and blood-brain barrier changes after temporary and permanent middle cerebral artery occlusion in the rat. J Neurol Sci (1999) 166(2):91-99.
11. Abbruscato TJ, Davis TP: Combination of hypoxia/aglycemia compromises in vitro blood-brain barrier integrity. J Pharmacol Exp Ther (1999) 289(2):668-675.
12. Maples KR, Ma F, Zhang Y-K: Comparison of the radical trapping ability of PBN, S-PPBN and NXY-059. Free Radic Res (2001) 34(4):417-426.
13. Mason RP, Maples KR, Knecht KT: In vivo detection of free radical metabolites by spin trapping. In: Electron Spin Resonance. Symons MCR (Ed), Royal Society of Chemistry, London, UK (1999) 11B:1-10.
14. Cao X, Phillis JW: α-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res (1994) 644(2):267-272.
15. Kuroda S, Tsuchidate R, Smith M-L, Maples KR, Siesjö BK: Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab (1999) 19(7):778-787.
16. Peeling J, Del Bigio MR, Corbett D, Green AR, Jackson DM: Efficacy of disodium 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (NXY-059), a free radical trapping agent, in a rat model of hemorrhagic stroke. Neuropharmacology (2001) 40(3):433-439.
17. Zhao A, Cheng M, Maples KR, Ma JY, Buchan AM: NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat. Brain Res (2001) 909(1-2):46-50.
18. Yang Y, Li Q, Shuaib A: Neuroprotection by 2-h postischemia administration of two free radical scavengers, α-phenyl-N-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia. Exp Neurol (2000) 163(1):39-45.
19. Lapchak PA, Araujo DM, Song D, Wei J, Purdy R, Zivin JA: Effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit large clot embolic stroke model: Combination studies with tissue plasminogen activator. Stroke (2002) 33(6):1665-1670.
20. Sydserff SG, Borelli AR, Green AR, Cross AJ: Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window. Br J Pharmacol (2002) 135(1):103-112.
21. Gray C, Nukada H, Jackson DM, McMorran PD, Wu A, Ma F: Neuroprotective effects of nitrone radical scavenger S-PBN on reperfusion nerve injury in rats. Brain Res (2003) 982(2):179-185.
22. Pietri S, Liebgott T, Frejaville C, Tordo P, Culcasi M: Nitrone spin traps and their pyrrolidine analogs in myocardial reperfusion injury: Hemodynamic and ESR implications - evidence for a cardioprotective phosphonate effect for 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide in rat hearts. Eur J Biochem (1998) 254(2):256-265.
23. Vergely C, Tabard A, Maupoil V, Rochette L: Isolated perfused rat hearts release secondary free radicals during ischemia reperfusion injury: Cardiovascular effects of the spin trap α-phenyl N-tert-butylnitrone. Free Radical Res (2001) 35(5):475-489.
24. Kotamraju S, Konorev EA, Joseph J, Kalyanaraman B: Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem (2000) 275(43):33585-33592.
25. Ginsberg MD, Becker DA, Busto R, Belayev A, Zhang Y, Khoutorova L, Ley JJ, Zhao W, Belayev L: Stilbazulenyl nitrone, a novel antioxidant, is highly protective in focal ischemia. Ann Neurol (2003) 54(3):330-342.
26. Muratovska A, Lightowlers RN, Taylor RW, Wilce JA, Murphy MP: Targeting large molecules to mitochondria. Adv Drug Deliv Rev (2001) 49(1-2):189-198.
27. Erbs S, Gielen S, Linke A, Mobius-Winkler S, Adams V, Baither Y, Schuler G, Hambrecht R: Improvement of peripheral endothelial dysfunction by acute vitamin C application: Different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy. Am Heart J (2003) 146(2):280-285.
28. Suzuki K, Murtuza B, Sammut IA, Latif N, Jayakumar J, Smolenski RT, Kaneda Y, Sawa Y, Matsuda H, Yacoub MH: Heat shock protein 72 enhances manganese superoxide dismutase activity during myocardial ischemia-reperfusion injury, associated with mitochondrial protection and apoptosis reduction. Circulation (2002) 106(12 Suppl 1):1270-1276.
29. Green AR, Ashwood T, Odergren T, Jackson DM: Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059. Pharmacol Ther (2003) 100(3):195-214.
30. Lees KR, Barer D, Ford GA, Hacke W, Kostulas V, Sharma AK, Odergren T: Tolerability of NXY-059 at higher target concentrations in patients with acute stroke. Stroke (2003) 34(2):482-487.
31. Marshall JW, Cummings RM, Bowes LJ, Ridley RM, Green AR: Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion. Stroke (2003) 34(9):2228-2233.